Literature DB >> 3100063

Is there an interleukin 2 inhibitor in human serum?

R Lelchuk, J A Schmidt, K Hodson, R Aston, F Y Liew.   

Abstract

Normal mouse serum has been shown to contain an inhibitor of interleukin 2 (IL-2). Here we report that a molecule with similar activity cannot be found in normal human serum (NHS). Although NHS inhibited the IL-2-dependent proliferation of mouse CTLL cells, as expected of an IL-2 inhibitor, it also had inhibitory activity on IL-3-dependent cells and was cytolytic to IL-2-independent mouse cells as measured by a 51Cr release assay, indicating a nonspecific effect. In addition, NHS had no effect on the IL-2-dependent proliferation of human peripheral blood T-cell blasts. Fractionation of NHS by size exclusion HPLC failed to separate cytolytic activity from any putative true IL-2 inhibitor activity. The cytolytic component was not related to immunoglobulin since it had a molecular weight of 50,000 to 60,000 and was not bound by protein-A-Sepharose. However, its molecular weight, heat lability, and trypsin sensitivity suggest it to be a protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100063     DOI: 10.1016/0008-8749(87)90013-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  The effect of experimental haemocarbofiltration upon activity of mononuclear cells from normal and autoimmune patients.

Authors:  S A Grando; B T Glukhenky; G N Drannik; A P Kostromin; A B Romanenko
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

2.  Evidence of a plasma-mediated "window" of immunodeficiency in rats following trauma.

Authors:  C D Mills; M D Caldwell; D S Gann
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

3.  Interleukin 2 inhibitor in synovial fluid.

Authors:  P Emery; K C Gentry; A Kelso; I R Mackay
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.